PubRank

Roel G W Verhaak

Author PubWeight™ 96.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterizing the cancer genome in lung adenocarcinoma. Nature 2007 16.48
2 Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010 16.12
3 The somatic genomic landscape of glioblastoma. Cell 2013 11.73
4 Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004 11.61
5 Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015 5.71
6 Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 2011 4.78
7 Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 2012 4.37
8 PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat Biotechnol 2011 3.57
9 Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 2011 3.27
10 Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013 2.94
11 Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 2013 2.84
12 Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood 2007 2.77
13 Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet 2006 2.10
14 A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J Clin Invest 2007 1.63
15 A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes Dev 2013 1.55
16 Differential regulation of Foxo3a target genes in erythropoiesis. Mol Cell Biol 2007 1.26
17 Predicting time to ovarian carcinoma recurrence using protein markers. J Clin Invest 2013 1.17
18 Unifying gene expression measures from multiple platforms using factor analysis. PLoS One 2011 1.06
19 The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn 2012 1.02
20 Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia. Cancer Res 2006 0.94
21 Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. Clin Cancer Res 2012 0.91
22 Studying a complex tumor: potential and pitfalls. Cancer J 2012 0.87
23 Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain. Acta Neuropathol 2015 0.86
24 SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels. BMC Genomics 2008 0.85
25 Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer. J Clin Invest 2015 0.79
26 Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell 2016 0.76
27 Regulation of mRNA expression in breast cancer - a cis-tematic trans-action. Breast Cancer Res 2012 0.75
28 Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer. J Clin Invest 2016 0.75